Mark Maietta

President and Chief Commercial Officer YPrime

Last Reviewed: September 28, 2026

Executive Summary

Mark Maietta is President and Chief Commercial Officer of YPrime, a Malvern, Pennsylvania company that supplies the technology behind clinical trials: electronic clinical outcome assessment (eCOA), interactive response technology (IRT) for randomisation and drug supply, and eConsent. He joined in 2016 as Chief Commercial Officer and in August 2018 was also named President, taking responsibility for the strategic direction of the company’s growth. Today he directs YPrime’s commercial strategy, with oversight of sales, business development and commercial operations, and works under a separate Chief Executive Officer. His career of nearly three decades has been spent almost entirely on the commercial side of life sciences services and technology.

Career Highlights

• President and Chief Commercial Officer of YPrime, overseeing sales, business development and commercial operations.
• Named President in August 2018, in addition to his existing role as Chief Commercial Officer, which he had held since joining in 2016.
• Listed as an executive officer of Y-Prime, Inc. in a 2017 SEC Form D filing.
• Chief Commercial Officer of Clariness, a digital patient recruitment and engagement company, where he built and led its global commercial infrastructure.
• Chief Business Officer of AdviseClinical, a clinical strategic advisory and staffing organisation.
• Appointed Senior Vice President for Global Business Development and a member of the executive team at CRF Health in July 2012.

Professional Journey

Maietta studied marketing at Ithaca College and later earned an MBA from Binghamton University. His early career was in the pharmaceutical industry itself and the data businesses around it, with positions at Pfizer, Novartis Pharmaceuticals and OPTUMInsight, now part of UnitedHealth Group.

In July 2012 CRF Health, a provider of electronic patient-reported outcome technology for clinical trials, appointed him Senior Vice President for Global Business Development and a member of its executive team. YPrime describes his tenure there as a period in which he redesigned business development and marketing practices and helped to build a global industry leader. He then became Chief Business Officer at AdviseClinical, a clinical strategic advisory and staffing firm, and after that Chief Commercial Officer of Clariness, which provides digital patient recruitment and engagement services. At Clariness he built and led the global commercial infrastructure.

He joined YPrime in 2016 as Chief Commercial Officer. YPrime, founded in 2006 by Shawn Blackburn, had grown from eClinical systems for patient management, clinical supplies and drug accountability into cloud-based IRT and eCOA platforms. A Form D filed with the SEC in November 2017 lists Maietta as one of the company’s executive officers. In August 2018 YPrime announced that he would also serve as President. Blackburn, then chief executive, said Maietta’s record of delivering results and building high-growth businesses would help the company adapt as digital health changed clinical research.

YPrime’s leadership has changed since then. Ian Lennox is now Chief Executive Officer and Blackburn serves as Founder and Director. Maietta continues as President and Chief Commercial Officer, leading the commercial side of a business that now covers eCOA, IRT, eConsent and participant engagement for sponsors and contract research organisations.

Education

Binghamton University

MBA

Ithaca College

BS, Marketing